Market
Overview:
A microcarrier can be defined as a support matrix that would allow
the growth of adherent cells. It can benefit from a number of factors like
large culture surface area, better cell yields, and reduced risk of
contamination can provide advantage to the global market for microcarriers.
Various companies and research institutes can also make sure that the growth
goes beyond the expected market rate.
Growing demand for cell-based vaccine is a key factor enhancing
the growth of the global Microcarriers
Market Size. Cell culture techniques have gained widespread acceptance
in the study of cell function, cell differentiation, and cell structure are
vital tools in the production of biological materials such as vaccines,
hormones, interferons, enzymes, antibodies, and nucleic acids. Microcarrier technology
is extensively leveraged by research institutes and life science companies for
various cell-based applications.
Microcarriers allow for convenient surface for the growth of
adherent cells and facilitate increasing the yield of cells products. They are
also applied to isolation of cells, studies on differentiation and cell
function, harvesting mitotic cells, membrane studies and others. Advances in media
formulation, improvement in processing technologies, and progress in cell
characterization techniques have helped the global microcarriers market move
ahead. Moreover, technological advancements in microcarriers has resulted in
increased productivity which ultimately leads to decreased cost which is
fostering the growth of the global microcarriers market.
Competitive
Landscape:
Corning Incorporated,
Sartorius AG, Merck KGaA, HiMedia Laboratories, Danaher, GENERAL ELECTRIC
COMPANY, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Lonza , and Eppendorf AGv are the eminent players in the
global microcarriers market.
Segmentation:
·
The global
microcarriers market has been segmented based on product type, application, a
nd end user.
·
By product type,
the global; microcarriers market has been segmented into equipment, and
consumables. the equipment segment has been further segmented into bioreactors,
culture vessels, cell counters, filtration systems, and other equipment.
·
The consumables
segment has been further segmented into media, reagents, and microcarrier
beads. The media sub-segment has been further segmented into serum-based media,
serum-free media, and other media. The microcarrier beads sub-segment has been
further segmented into cationic microcarriers, collagen-coated microcarriers,
protein-coated microcarriers, and other microcarrier beads.
·
By application,
the global microcarriers market has been segmented into vaccine manufacturing,
cell therapy, biologics manufacturing, and other applications.
·
By end user, the
global microcarriers market has been segmented into pharmaceutical and
biotechnology companies, research institutes, and contract research
organizations. The pharmaceutical and biotechnology companies’ segment is leading
the market. heightened use of single-use technologies in vaccine production and
expanding application area of microcarriers in the pharmaceutical and
biotechnology companies can be credited for the growth of the market. The
research institutes segment is expected to be the fastest growing segment due
to increased life-threatening diseases R&D activities.
Regional Analysis:
By region, the global microcarriers market has been segmented into
the America, Asia Pacific (APAC), Europe, and the Middle East & Africa
(MEA).
High occurrence of cancer and other chronic diseases along with a
robust healthcare sector is supporting the growth of the Americas market. Increase
in number of venture capital investment and favorable reimbursement landscape
are other factors boosting the market growth.
Europe follows the Americas closely and is the second largest
market for microcarriers. the growth of the Europe market can be attributed to
the availability of funds for R&D and accessibility of technologically
advanced products. Moreover, various biopharmaceutical companies in the region
are entering into strategic partnerships which is expected to augur well for
the growth of the market.
APAC market is anticipated to grow at a relatively faster pace
than owing to the presence of a vast patient pool, growing demand for
cell-based vaccines, and the availability of funds for cell-based research.
The MEA market
accounts for the minimum share of the global market where the Middle East
accounts for the majority share of the market. Increased government initiatives
for the development of the healthcare sector is favoring the growth of the
market.
NOTE : Our team of researchers are studying
Covid19 and its impact on various industry verticals and wherever required we
will be considering covid19 footprints for a better analysis of markets and
industries. Cordially get in touch for more details.
Comments
Post a Comment